Towards Healthcare

News

Your marketplace is evolving, your competitors are readjusting – but instead of reacting you can proact

Evaxion Launches AI-Powered Vaccine Program to Target Deadly Strep Infections
27 June 2025

Evaxion Launches AI-Powered Vaccine Program to Target Deadly Strep Infections

Evaxion’s New Vaccine Program Image Credits: University of Alberta Announcement Evaxion, a techbio company leading in the development of AI-Immunology powered vaccines, has introduced a new vaccine program that is an add-on to the R&D pipeline. The company is encouraged to introduce a...

Bavarian Nordic Begins Clinical Trials of Mpox Vaccine for Pregnant Women and Infants
27 June 2025

Bavarian Nordic Begins Clinical Trials of Mpox Vaccine for Pregnant Women and Infants

Bavarian Nordic’s First of Two Clinical Trials Image Credits: MedWatch Announcement Bavarian Nordic has initiated the first of two clinical trials to contribute to the use and approval of the MVA-BN mpox/smallpox vaccine for pregnant or breastfeeding women and 2-year-old infants. Further,...

ProFound Therapeutics and Novartis Join Forces to Develop New Heart Disease Treatments
27 June 2025

ProFound Therapeutics and Novartis Join Forces to Develop New Heart Disease Treatments

ProFound Therapeutics, in collaboration with Novartis Image Credits: PharmaLive Which New Collaboration is Currently Streaming in the Healthcare Market? ProFound Therapeutics company focused on the human proteome to discover new medicines for various diseases, has entered into a collaboration w...

Sanofi’s Riliprubart Gets Orphan Drug Designation from FDA for Organ Transplant Rejection
26 June 2025

Sanofi’s Riliprubart Gets Orphan Drug Designation from FDA for Organ Transplant Rejection

Riliprubart is Designated as an Orphan Drug in the US Image Credits: Yahoo Finance Announcement The US Food and Drug Administration approved Rilpivirine, positioning it as an orphan drug designation. Rilipubart, an investigational treatment for antibody-mediated rejection (AMR) in solid organ t...

Recordati and Amarin Partner to Expand Heart Drug Vazkepa Across 59 Countries
26 June 2025

Recordati and Amarin Partner to Expand Heart Drug Vazkepa Across 59 Countries

Recordati’s Agreement with Amarin Image Credits: Fierce Pharma Announcement Recordati, an international pharmaceutical company, signed a license and supply agreement with Amarin, a company known for the treatment of cardiovascular diseases. The agreement’s purpose is to present a ma...

Verastem Doses First Patient in U.S. Trial for Oral KRAS G12D Inhibitor VS-7375
26 June 2025

Verastem Doses First Patient in U.S. Trial for Oral KRAS G12D Inhibitor VS-7375

Verastem Oncology’s oral KRAS G12D (ON/OFF) Inhibitor in the First Patient Image Credits: Stock Titan Announcement Verastem Oncology, a biopharmaceutical company known for introducing new medicines for patients suffering from cancer-related RAS/MAPK, has announced that the first patient h...

Fortrea Collaborates with Emery Pharma to Ensure Rifampin Safety in Early-Phase Drug Studies
26 June 2025

Fortrea Collaborates with Emery Pharma to Ensure Rifampin Safety in Early-Phase Drug Studies

Emery and Fortrea Pharma’s Collaboration Image Credits: Stock Titan Announcement Fortrea pharma, a known contract research organization (CRO), entered into a collaboration with Emery pharma, an analytical and bioanalytical CRO. The collaboration is initiated to deliver testing services un...

Zambon Gets Approval to Launch Fluimucil IV in China for Respiratory Treatment
25 June 2025

Zambon Gets Approval to Launch Fluimucil IV in China for Respiratory Treatment

Zambon Approval and Entry into China Image Credits: Farmacia Rubino Announcement A multinational chemical pharmaceutical company, Zambon, known for its innovative care and cure, has received approval from Chinese regulatory authorities. Zambon received approval due to its vigorous local clinica...

Susan G. Komen Invests $10.8 Million in Breast Cancer Research to Drive Innovation and Equity
25 June 2025

Susan G. Komen Invests $10.8 Million in Breast Cancer Research to Drive Innovation and Equity

Susan G. Komen’s Investment in Breast Cancer Research Image Credits: Susan G Komen Announcement Susan G. Komen, a known breast cancer organization, has invested $10.8 million in new research that will accelerate innovation in science and deliver effective solutions to patients suffering f...

SpaceX Plans to Boost Vietnam’s Healthcare with Satellite Internet Expansion
25 June 2025

SpaceX Plans to Boost Vietnam’s Healthcare with Satellite Internet Expansion

SpaceX’s Entry in Vietnam? Image Credits: The Economic Times Announcement SpaceX, an American space technology company, has planned an expansion in Vietnam, expecting an opportunity in the healthcare market of the region that is open to adopting a digital transformation. Director of enter...